RNA interference with special reference to combating viruses of crustacea

Indian Journal of Virology

Volumn 23, Issue 2, 2012, Pages 226-243

  La Fauce, Kathy ^a   Owens, Leigh ^a  

^a JAMES COOK UNIVERSITY   (Australia)

Author keywords

Crustacea; MrNV; PmergDNV; RNA interference; TSV; Viruses; WSSV; YHV

Indexed keywords

COMPLEMENTARY RNA; LIPOPLEX; LIPOSOME; MESSENGER RNA; MICRORNA; MULTIPROTEIN COMPLEX; PLASMID VECTOR; POLYETHYLENEIMINE; RIBONUCLEASE III; RNA; RNA POLYMERASE; RNA PRECURSOR; SMALL INTERFERING RNA; VIRUS VECTOR;

ADENO ASSOCIATED VIRUS; ADENOVIRUS; AQUACULTURE; BACULOVIRUS; CRUSTACEA; DISEASE CONTROL; DNA SEQUENCE; GENE EXPRESSION; GENE REPRESSION; GENE SILENCING; GENE TRANSFER; GENETIC TRANSFECTION; HERPES SIMPLEX VIRUS; IMMUNOGENICITY; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; POSTTRANSCRIPTIONAL GENE SILENCING; PROMOTER REGION; PROTEIN SYNTHESIS; REVIEW; RNA INTERFERENCE; STABLE EXPRESSION; VACCINATION; VIRAL GENE DELIVERY SYSTEM; VIRUS; VIRUS GENOME; VIRUS INFECTION; VIRUS RECOMBINANT;

EID: 84872487206     PISSN: 09702822     EISSN: 09740120     Source Type: Journal    
DOI: 10.1007/s13337-012-0084-1     Document Type: Review

References (213)

1. Aigner A. Gene silencing through RNA interference (RNAi) in vivo: strategies based on the direct application of siRNAs. J Biotechnol. 2006;124:12-25.
2. Aldeman ZN, Sanchez-Vargas I, Travanty EA, Carlson JO, Beaty BJ, Blair CD, Olsen KE. RNA silencing of dengue virus type 2 replication in transformed C6/36 mosquito cells transcribing an inverted-repeat RNA derived from the virus genome. J Virol. 2002;76:12925-33.
3. Alder MN, Dames S, Gaudet J, Mango SE. Gene silencing in Caenorhabditis elegans by transitive RNA interference. RNA. 2003;9:25-32.
4. Aliyari R, Ding SW. RNA-based viral immunity initiated by the Dicer family of host immune receptors. Immunol Rev. 2009;176-188.
5. Alper S, Laws R, Lackford B, Boyd WA, Dunlap P, Freedman JH, Schwartz DA. Identification of innate immunity genes and pathways using a comparative genomics approach. Proc Natl Acad Sci USA. 2008;105:7016-21.
6. Amarzguioui M, Rossi JJ, Kim D. Approaches for chemically synthesized siRNA and vector-mediated RNAi. FEBS Lett. 2005;579:5974-81.
7. Ambrose V, Lee RC, Lavanway A, Williams PT, Jewell D. MicroRNAs and other tiny endogenous RNAs in C. elegans. Curr Biol. 2003;13:807-18.
8. Anandalakshmi R, Pruss GJ, Ge X, Marathe R, Mallory AC, Smith TH, Vance VB. A viral suppressor of gene silencing in plants. Proc Natl Acad Sci USA. 1998;95:13079-84.
9. Aravin AA, Naumova NM, Tulin AT, Vagin VV, Rozovsky YM, Gvozdev VA. Double-stranded RNA-mediated silencing of genomic tandem repeats and transposable elements in the D. melanogaster germ line. Curr Biol. 2001;11:1017-27.
10. Bartell DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116:281-97.
11. Bastin P, Galvani A, Sperling L. Genetic interference in protozoa. Res Microbiol. 2001;302:316-23.
12. Baulcombe D. RNA silencing in plants. Nature. 2004;431:356-63.
13. Baulcombe D. RNA silencing. Trends Biochem Sci. 2005;30:290-3.
14. Beclin C, Berthome R, Palaqui JC, Tepfer M, Vaucheret H. Infection of tobacco or Arabidopsis plants by CMV counteracts systemic post-transcriptional silencing of nonviral (trans) genes. Virology. 1998;252:313-7.
15. Berns N, Kusch T, Schroder R, Reuter R. Expression, function and regulation of Brachyenteron in the short germband insect Tribolium castaneum. Dev Genes Evol. 2008;218:169-79.
16. Bernstein E, Kim SY, Carmell MA, Murchinson EP, Alcorn H, Li MZ, Mills AA, Elledge SJ, Anderson KV, Hannon GJ. Dicer is essential for mouse development. Nature Genet. 2003;35:215-7.
17. Beye M, Hartel S, Hagen A, Hasselmann M, Omholt SW. Specific developmental gene silencing in the honey bee using a homeobox motif. Insect Mol Biol. 2002;11:527-32.
18. Borchard G. Chitosans for gene delivery. Adv Drug Deliv Rev. 2001;52:145-50.
19. Boussif O, Lezoulach F, Zanta MA, Mergny MD, Scherman D, Demeneix B, Bher JP. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc Natl Acad Sci USA. 1995;92:7297-301.
20. Braunstein TH, Moury B, Johannessen M, Albreshtsen M. Specific degradation of 3′ regions of GUS mRNA in posttranscriptionally silenced tobacco lines may be related to 5′-3′ spreading of silencing. RNA. 2002;8:1034-44.
21. Brigneti G, Voinnet O, Li WX, Ji LH, Ding SW, Baulcombe DC. Viral pathogenicity determinants are suppressors of transgene silencing in Nicotiana benthamiana. EMBO J. 1998;17:6739-46.
22. Brummelkamp TR, Bernards R, Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science. 2002;296:550-3.
23. Bumcrot D, Manoharan M, Koteliansky V, Sah DW. RNAi therapeutics: a potential new class of pharmaceutical drugs. Nat Chem Biol. 2006;2:711-9.
24. Burmingham A, Anderson EM, Reynolds A, Ilsley-Tyree D, Leake D, Fedorov Y, Baskerville S, Maksimova E, Robinson K, Karpilow J, Marshall WS, Khvorova A. 3′ UTR seed matches, but not overall identity, are associated with RNAi off-targets. Nat Methods. 2006;3:199-204.
25. Caplen NJ, Parrish S, Imani F, Fire A, Morgan RA. Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems. Proc Natl Acad Sci USA. 2001;98:9742-7.
26. Caplen NJ, Zheng Z, Falgout B, Morgan RA. Inhibition of viral gene expression and replication in mosquito cells by dsRNA-triggered RNA interference. Mol Ther. 2002;6:243-51.
27. Cottrell TR, Doering TL. Silence of the strands: RNA interference in eukaryotic pathogens. Trends Microbiol. 2003;11:37-43.
28. Curiel DT, Agarwal S, Wagner E, Cotten M. Adenovirus enhancement of transferrin-polysine-mediated gene delivery. Proc Natl Acad Sci USA. 1991;88:8850-4.
29. Dang LT, Kondo H, Hirono I, Aoki T. Inhibition of red seabream iridovirus (RSIV) replication by small interfering RNA (siRNA) in a cell culture system. Antiviral Res. 2008;77:142-9.
30. de Fougerolles AR. Delivery vehicles for small interfering RNA in vivo. Hum Gene Ther. 2008;19:125-32.
31. de Fougerolles AR, Manoharan M, Meyers R, Vornlocher HP. RNA interference in vivo: toward synthetic small inhibitory RNA-based therapeutics. Methods Enzymol. 2005;392:278-96.
32. Dillon A. The specifics of small interfering RNA specificity. Proc Natl Acad Sci USA. 2003;100:6289-91.
33. Doench JG, Petersen CP, Sharp PA. siRNAs can function as miRNAs. Genes Dev. 2003;17:438-42.
34. Donze O, Picard D. RNA interference in mammalian cells using siRNAs synthesized with T7 RNA polymerase. Nucleic Acids Res. 2002;30:e46.
35. Downward J. RNA interference. Clin Rev. 2004;328:1245-8.
36. Duxbury MS, Whang EE. RNA interference: a practical approach. J Surg Res. 2004;117:339-44.
37. Dykxhoorn DM, Novina CD, Sharp PA. Killing the messenger: short RNAs that silence gene expression. Nat Rev. 2003;4:457-67.
38. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature. 2001;411:494-8.
39. Elbashir SM, Lendeckel W, Tuschi T. RNA interference is mediated by 21- and 22-nucleotide RNAs. Genes Dev. 2001;15:188-200.
40. Elbashir SM, Martinez J, Patkaniowska A, Lendeckel W, Tuschi T. Functional anatomy of siRNAs for mediating efficient RNAi in Drosophila melanogaster embryo lysate. EMBO J. 2001;20:6877-88.
41. Elbashir SM, Harborth J, Weber K, Tuschl T. Analysis of gene function in somatic mammalian cells using small interfering RNAs. Methods. 2002;26:199-213.
42. Evans CH, Gouze E, Gouze JN, Robbins PD, Ghivizzani SC. Gene therapeutic approaches-transfer in vivo. Adv Drug Deliv Rev. 2006;58:243-58.
43. Fagard M, Vaucheret H. (Trans) gene silencing in plants: How many mechanisms? Ann Rev Plant Physiol Plant Mol Biol. 2000;51:167-94.
44. Ferrari FK, Samulski T, Shenk T, Samulski RJ. Second-strand synthesis is a rate-limiting step for efficient transduction by recombinant adeno-associated virus vectors. J Virol. 1996;70:3227-34.
45. Fire A, Xu SQ, Montgomery MK, Kostas MK, Driver SE, Mello CC. Potent of specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature. 1998;391:806-11.
46. Fischer D, Bieber T, Brusselbach S, Elsasser HP, Kissel T. Cationized human serum albumin as a non-viral vector system for gene delivery? Characterization of complex formation with plasmid DNA and transfection efficiency. Int J Pharm. 2001;225:97-111.
47. Gao X, Huang L. Cationic liposome-mediated gene transfer. Gene Ther. 1995;2:710-22.
48. Ge Q, McManus MT, Nguyen T, Shen CH, Sharp PA, Eisen HN, Chen J. RNA interference of influenza virus production by directly targeting mRNA for degradation and indirectly inhibiting all viral RNA transcription. Proc Natl Acad Sci USA. 2003;100:2718-23.
49. Goncalves MAFV, Pau MG, de Vries AAF, Valerio D. Generation of a high capacity hybrid vector: packaging of recombinant adenoassociated virus replicative intermediates in adenovirus capsids overcomes the limited cloning capacity of adenoassociated virus vectors. Virology. 2001;288:236-46.
50. Goncalves MAFV, van der Velde I, Janssen JM, Maassen BTH, Heemskerk EH, Opstelten DJE, Knaan-Shanzer S, Valerio D, de Vries AAF. Efficient generation and amplification of high-capacity adeno-associated virus/adenovirus hybrid vectors. J Virol. 2002;76:10734-74.
51. Graham FL, Prevec L. Methods for construction of adenovirus vectors. Mol Biotechnol. 1995;3:207-20.
52. Grimm D, Streetz KL, Jopling CL, Storm TA, Pandey K, Davis CR, Marion PL, Salazar FH, Kay MA. Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways. Nature. 2006;441:537-41.
53. Gu W, Putral L, Hengst K, Minto K, Saunders NA, Leggatt G, McMillan NA. Inhibition of cervical cancer cell growth in vitro and in vivo with lentiviral-vector delivered short hairpin RNA targeting human papillomavirus E6 and E7 oncogenes. Cancer Gene Ther. 2006;13:1023-32.
54. Gu W, Putral L, McMillan N. siRNA and shRNA as anticancer agents in a cervical cancer model. Methods in Mol Biol. 2008;442:159-72.
55. Hamilton AJ, Baulcombe DC. A species of small antisense RNA in posttranscriptional gene silencing in plants. Science. 1999;286:950-2.
56. Hammond SM. Dicing and slicing: the core machinery of the RNA interference pathway. FEBS Lett. 2005;579:5822-9.
57. Han Y, Grierson D. The influence of inverted repeats on the production of small antisense RNAs involved in gene silencing. Mol Genet Genomics. 2002;267:629-35.
58. Hannon GJ. RNA interference. Nature. 2002;418:244-51.
59. Hannon GJ, Rossi JJ. Unlocking the potential of the human genome with RNA interference. Nature. 2004;431:371-8.
60. Hasuwa H, Kaseda K, Einarsdottir T, Okabe M. Small interfering RNA and gene silencing in transgenic mice and rats. FEBS Lett. 2002;532:227-30.
61. Hayakijkosol O, Owens L. B2 or not B2: RNA interference reduces Macrobrachium rosenbergii nodavirus replication in redclaw crayfish (Cherax quadricarinatus). Aquaculture. 2012;326-329:40-5.
62. He F, Syed SM, Hameed ASS, Kwang J. Viral ubiquitin ligase WSSV222 is required for efficient white spot syndrome virus replication in shrimp. J Gen Virol. 2009;90:1483-90.
63. Heidel JD, Yu Z, Liu JY, Rele SM, Liang Y, Zeidan RK, Kornbrust DJ, Davis ME. Administration in non-human primates of escalating intravenous doses of targeted nanoparticles containing ribonucleotide reductase subunit M2 siRNA. Proc Natl Acad Sci USA. 2007;104:5715-21.
64. Herweijer H, Wolff JA. Progress and prospects: naked DNA gene transfer and therapy. Gene Ther. 2003;10:453-8.
65. Hoa NT, Keene KM, Olsen KE, Zheng L. Characterization of RNA interference in an Anopheles gambiae cell line. Insect Biochem Mol Biol. 2003;33:949-57.
66. Holen T, Amarzguioui M, Wiiger MT, Babaie E, Prydz H. Positional effects of short interfering RNAs targeting the human coagulation trigger Tissue Factor. Nucleic Acids Res. 2002;30:1757-66.
67. Hooft van Iddekinge BJL, Smith GE, Summers MD. Nucleotide sequence of the polyhedrin gene of Autographa californica nuclear polyhedrosis virus. Virology. 1983;131:561-5.
68. Howard MK, Kershaw T, Gibb B, Storey N, MacLean AR, Zeng BY, Tel BC, Jenne P, Brown SM, Woolf CJ, Anderson PN, Coffin RS, Latchman DS. High efficiency gene transfer to the central nervous system of rodents and primates using herpes virus vectors lacking functional ICP27 and ICP34.5. Gene Ther. 1998;5:1137-47.
69. Howard KA, Rahbek UL, Liu X, Damgaard MB, Glud SZ, Andersen MO, Hovgaard MB, Schmitz A, Nyengaard JR, Besenbacher F, Kjems J. RNA interference in vitro and in vivo using a novel chitosan/siRNA nanoparticle system. Mol Ther. 2006;14:476-84.
70. Hutvagner G, Zamore PD. A microRNA in a multiple-turnover RNAi enzyme complex. Science. 2002;297:2056-60.
71. Jackson AL, Linsley PS. Noise amidst the silence: Off-target effects of siRNAs? Trends Genet. 2004;20:521-4.
72. Jackson AL, Bartz SR, Schelter J, Kobayashi SV, Burchard J, Mao M, Li B, Cavet G, Linsley PS. Expression profiling reveals off-target gene regulation by RNAi. Nat Biotechnol. 2003;21:635-7.
73. Jackson AL, Burchard J, Schelter J, Chau BN, Cleary M, Lim L, Linsley PS. Widespread siRNA 'off-target' transcript silencing mediated by seed region sequence complementarity. RNA. 2006;12:1179-87.
74. John M, Constien R, Akinc A, Goldberg M, Moon YA, Spranger M, Hadwiger P, Soutschek J, Vorn-Locher HP, Manorharan M, Stoffel M, Langer R, Anderson DG, Horton JD, Koteliansky V, Bumcrot D. Effective RNAi-mediated gene silencing without interruption of the edogenous microRNA pathway. Nature. 2007;449:745-7.
75. Judge AD, Sood V, Shaw JR, Fang D, McClintock K, MacLachlan I. Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA. Nature Biotechnol. 2005;23:457-62.
76. Kamath RS, Fraser AG, Dong Y, Poulin G, Durbin R, Gotta M, Kanapin A, Le Bot N, Moreno S, Sohrmann M, Welchman DP, Zipperlen P, Ahringer J. Systematic functional analysis of the Caenorhabditis elegans genome using RNAi. Nature. 2003;421:237-321.
77. Kavi HH, Fernandez H, Xie W, Birchler JA. RNA silencing in drosophila. FEBS Lett. 2005;579:5940-9.
78. Kawasaki H, Suyama E, Iyo M, Taira K. siRNAs generated by recombinant human Dicer induce specific and significant but target site-independent gene silencing in human cells. Nucleic Acids Res. 2003;31:981-7.
79. Kay MA, Glorioso JC, Naldini L. Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics. Nat Med. 2001;7:33-40.
80. Kennerdell JR, Carthew RW. Use of dsRNA-mediated genetic interference to demonstrate that frizzled and frizzled 2 act in the wingless pathway. Cell. 1998;95:1017-26.
81. Ketting RF, Fischer SEJ, Bernstein E, Sijen T, Hannon GJ, Plasterk RHA. Dicer functions in RNA interference and in synthesis of small RNA involved in developmental timing in C. elegans. Genes Dev. 2001;15:2654-9.
82. Khvorova A, Reynolds A, Jayasena SD. Functional siRNAs and miRNAs exhibit strand bias. Cell. 2003;115:209-16.
83. Kim DH, Behlke MA, Rose SD, Chang MS, Choi S, Rossi JJ. Synthetic dsRNA Dicer substrates enhance RNAi potency and efficacy. Nat Biotechnol. 2004;23:222-6.
84. Kim DH, Longo M, Han Y, Lundberg P, Cantin E, Rossi JJ. Interferon induction by siRNAs and ssRNAs synthesised by phage polymerase. Nat Biotechnol. 2004;22:321-5.
85. Koeberl DD, Alexander IE, Halbert CL, Russell DW, Miller AD. Persistent expression of human clotting factor IX from mouse liver after intravenous injection of adeno-associated virus vectors. Proc Natl Acad Sci USA. 1997;94:1426-31.
86. Kronke J, Kittler R, Buchholz F, Windisch MP, Pietschmann T, Bartenschlager R, Frese M. Alternative approaches for efficient inhibition of hepatitis C virus RNA replication by small interfering RNAs. J Virol. 2004;78:3436-46.
87. Krougliak V, Graham FL. Development of cell lines capable of complementing E1, E4, and protein IX defective adenovirus type 5 mutants. Hum Gene Ther. 1995;6:1575-86.
88. Kubo S, Mitani K. A new hybrid system capable of efficient lentiviral vector production and stable gene transfer mediated by a single helper-dependent adenoviral vector. J Virol. 2003;77:2694-971.
89. Kuemmerle NB, Lin PS, Krieg RJ, Lin KC, Ward KP, Chan JCM. Gene expression after intrarenal injection of plasmid DNA in the rat. Pediatr Nephrol. 2000;14:152-7.
90. Kumar P, Wu H, McBride JL, Jung KE, Kim MH, Davidson BL, Lee SK, Shankar P, Manjunath N. Transvascular delivery of small interfering RNA to the central nervous system. Nature. 2007;448:505-14.
91. Kuzio J, Rohel DZ, Curry CJ, Krebs A, Carstens EB, Faulkner P. Nucleotide sequence of the p10 polypeptide gene of Autographa californica nuclear polyhedrosis virus. Virology. 1984;139:414-8.
92. La Fauce KA, Owens L. The use of insects as a bioassay for Penaeus merguiensis densovirus (PmergDNV). J Invert Pathol. 2008;98:1-6.
93. La Fauce KA, Owens L. RNA interference reduces PmergDNV expression and replication in an in vivo cricket model. J Invert Pathol. 2009;100:111-5.
94. LaCount D, Bruse S, Hill KL, Donelson JE. Double-stranded RNA interference in Trypanosoma burcei using head-to-head promoters. Mol Biochem Parasitol. 2000;111:67-76.
95. Lechardeur D, Verkman AS, Lukacs GL. Intracellular routing of plasmid DNA during non-viral gene transfer. Adv Drug Deliv Rev. 2005;57:755-67.
96. Lee SH, Shinko PJ. siRNA-getting the message out. Eur J Pharm Sci. 2006;27:401-10.
97. Lee DF, Chen CC, Hsu TA, Juang JL. A baculovirus superinfection system: efficient vehicle for gene transfer into Drosophila S2 cells. J Virol. 2000;74:11873-80.
98. Lee TWR, Matthews DA, Blair GE. Novel molecular approaches to cystic fibrosis gene therapy. Biochem J. 2005;387:1-15.
99. Lehrman S. Virus treatment questioned after gene therapy death. Nature. 1999;401:517-8.
100. Leisy DJ, Rohrmann GF, Nesson M, Beaudreau GS. Nucleotide sequencing and transcriptional mapping of the Orgyia pseudotsugata multicapsid nuclear polyhedrosis virus p10 gene. Virology. 1986;153:157-67.
101. Lewis P, Hensel M, Emerman M. Human immunodeficiency virus infection of cells arrested in the cell cycle. EMBO J. 1992;11:3053-8.
102. Li WX, Ding SW. Viral suppressors of RNA silencing. Curr Opin Biotechnol. 2001;12:150-4.
103. Li HW, Li WX, Ding SW. Induction and suppression of RNA silencing by an animal virus. Science. 2002;296:1319-21.
104. Li X, Scuderi A, Letsou A, Virshup DM. B56-associated protein phosphatase 2A is required for survival and protects from apoptosis in Drosophila melanogaster. Mol Cell Biol. 2002;22:3674-84.
105. Lilley CE, Groutsi F, Han Z, Palmer JA, Anderson PN, Latchman DS, Coffin RS. Multiple immediate-early gene deficient herpes simplex virus vectors allowing efficient gene delivery to neurons in culture and widespread gene delivery to the central nervous system. J Virol. 2001;75:4343-56.
106. Lim LP, Lau NC, Garrett-Engele P, Grimson A, Schelter JM, Castle J, Bartel DP, Linsley PS, Johnson JM. Microarray analysis shows that some microRNAs do downregulate large numbers of target mRNAs. Nature. 2005;433:769-73.
107. Lin X, Ruan X, Anderson MG, McDowell JA, Kroeger PE, Fesik SW, Shen Y. siRNA-mediated off-target gene silencing triggered by a 7 nt complementation. Nucleic Acids Res. 2005;33:4527-35.
108. Lin CC, Hsu JTA, Huang KL, Tang HK, Lai YL. Stable RNA interference in Spodoptera frugiperda cells by a DNA vector-based method. Biotechnol Lett. 2006;28:271-7.
109. Lipardi C, Wei Q, Paterson BM. RNAi as random degradative PCR: siRNA primers convert mRNA into dsRNAs that are degraded to generate new siRNAs. Cell. 2001;107:297-307.
110. Liu F, Huang L. Development of non-viral vectors for systemic gene delivery. J Control Release. 2002;78:259-66.
111. Liu Q, Muruve DA. Molecular basis of the inflammatory response to adenovirus vectors. Gene Ther. 2003;10:935-40.
112. Liu H, Jiravanichpaisal P, Soderhall I, Cerenius L, Soderhall K. Antilipopolysaccharide factor interferes with white spot syndrome virus replication in vitro and in vivo in the crayfish Pacifastacus leniusculus. J Virol. 2006;80:10365-71.
113. Liu H, Soderhall K, Jiravanichpaisal P. Antiviral immunity in crustaceans. Fish Shellfish Immunol. 2009;27:79-88.
114. Liu B, Tang X, Zhan W. Interaction between white spot syndrome virus VP26 and hemocyte membrane of shrimp Fenneropenaeus chinensis. Aquaculture. 2011;314:13-7.
115. Lois C, Hong EJ, Pease S, Brown EJ, Baltimore D. Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors. Science. 2002;295:868-72.
116. Ma JB, Ye K, Patel DJ. Structural basis for overhang-specific small-interfering RNA recognition by the PAZ domain. Nature. 2004;429:318-22.
117. Maeda S. Expression of foreign genes in insects using baculovirus vectors. Annu Rev Entomol. 1989;34:351-72.
118. Malhotra P, Dasaradhi PVN, Kumar A, Mohammed A, Agrawal N, Bhatnager RK, Chauhan VS. Double-stranded RNA-mediated gene silencing of cysteine proteases (falcipain-1 and -2) of Plasmodium falciparum. Mol Microbiol. 2002;45:1245-54.
119. Marshall E. Gene therapy death prompts review of adenovirus vector. Science. 1999;286:2244-5.
120. Matzke MA, Primig M, Trnovsky J, Matzke AJ. Reversible methylation and inactivation of marker genes in sequentially transformed tobacco plants. EMBO J. 1989;8:643-9.
121. McCaffrey AP, Nakai H, Pandey K, Huang Z, Salazar FH, Xu H, Weiland SF, Marion PL, Kay MA. Inhibition of hepatitis B virus in mice by RNA interference. Nat Biotechnol. 2003;21:639-44.
122. McSwiggen JA, Seth S. A potential treatment for pandemic influenza using siRNAs targeting conserved regions of influenza A. Expert Opin Biol Ther. 2008;8:299-313.
123. Mehier-Humbert S, Guy RH. Physical methods for gene transfer: improving the kinetics of gene delivery into cells. Adv Drug Deliv Rev. 2005;57:733-53.
124. Miki D, Itoh R, Shimamoto K. RNA silencing of single and multiple members in a gene family of rice. Plant Physiol. 2005;138:1903-13.
125. Miller LK. Baculoviruss as gene expression vectors. Ann Rev Microbiol. 1988;42:177-99.
126. Mittal V. Improving the efficiency of RNA interference in mammals. Nat Rev Genet. 2004;5:355-65.
127. Murphy SJ, Chong H, Bell S, Diaz RM, Vile RG. Novel integrating adenoviral/retroviral hybrid vector for gene therapy. Hum Gene Ther. 2002;13:745-60.
128. Naldini L, Blomer U, Gage FH, Trono D, Verma IM. Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc Natl Acad Sci USA. 1996;93:11382-8.
129. Naldini L, Blomer U, Gallay P, Ory D, Mulligan R, Gage FH, Verma IM, Trono D. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science. 1996;272:263-7.
130. Napoli C, Lemieux C, Jorgensen R. Introduction of a chimeric chalcone synthase gene into petunia results in reversible co-suppression of homologous genes in trans. Plant Cell. 1990;2:279-89.
131. Nasevicuis A, Ekker SC. Effective targeted gene 'knockdown' in zebrafish. Nat Genet. 2000;26:216-20.
132. Nehyba J, Hrdlickova R, Bose HR. Dynamic evolution of immune system regulators: the history of the interferon regulatory factor family. Mol Biol Evol. 2009;26:2539-50.
133. Novina CD, Sharp PA. The RNAi revolution. Nature. 2004;430:161-4.
134. Nykanen A, Haley B, Zamore PD. ATP requirements and small interfering RNA structure in the RNA interference pathway. Cell. 2001;107:309-21.
135. Ongvarrasopone C, Saejia P, Chanasakulniyom M, Panyim S. Inhibition of Taura syndrome virus replication in Litopenaeus vannamei through silencing the LvRab7 gene using double-stranded RNA. Arch Virol. 2011;156:1117-23.
136. Paddison PJ, Caudy AA, Bernstein E, Hannon GJ, Conklin DS. Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells. Genes Dev. 2002;16:948-58.
137. Paddison PJ, Caudy AA, Hannon GJ. Stable suppression of gene expression by RNAi in mammalian cells. Proc Natl Acad Sci USA. 2002;99:1443-8.
138. Palombo F, Monciotti A, Recchia A, Cortese R, Ciliberto G, La Monica N. Site-specific integration in mammalian cells mediated by a new hybrid baculovirus- adeno-associated virus vector. J Virol. 1998;72:5025-34.
139. Parrish S, Fire A. Distinct roles for RDE-1 and RDE-4 during RNA interference in Caenorhabditis elegans. RNA. 2001;7:1397-402.
140. Petersen BO, Albrechtsen M. Evidence implying only unprimed RdRP activity during transitive gene silencing in plants. Plant Mol Biol. 2005;58:575-83.
141. Pfeifer A, Verma IM. Gene therapy: promises and problems. Annu Rev Genomics Hum Genet. 2001;2:177-211.
142. Pille JY, Li H, Blot E, Bertrand JR, Pritchard LL, Opolan P, Makisemnko A, Lu H, Vannier JP, Soria J, Malvy C, Soria C. Intravenous delivery of anti-RhoA small interfering RNA (siRNA) loaded in nanoparticles of chitosan in mice: safety and efficacy in xenografted aggressive breast cancer. Hum Gene Ther. 2006;17:1019-26.
143. Posiri P, Ongvarrasopone C, Panyim S. Improved preventative and curative effects of YHV infection in Penaeus monodon by a combination of two double stranded RNAs. Aquaculture. 2011;314:34-8.
144. Pouton CW, Lucas P, Thomas BJ, Uduehi AN, Milroy DA, Moss SH. Polycation-DNA complexes for gene delivery: a comparison of the biopharmaceutical properties of cationic polypeptides and cationic lipids. J Control Release. 1998;53:289-99.
145. Preston NP, Baule VJ, Leopold R, Henderling J, Atkinson S, Whyard S. Delivery of DNA to early embryos of the Kuruma prawn Penaeus japonicas. Aquaculture. 2000;181:225-34.
146. Qu F, Morris TJ. Suppressors of RNA silencing encoded by plant viruses and their role in viral infection. FEBS Lett. 2005;579:5958-64.
147. Raemdonck K, Vandenbroucke RE, Demeester J, Sanders NN, De Smedt SC. Maintaining the silence: reflections on long-term RNAi. Drug Discov Today. 2008;13:917-31.
148. Rajeshkumar S, Venkatsean C, Sarathi M, Sarathbabu V, Thomas J, Anver Basha K, Sahul Hameed AS. Oral delivery of DNA construct using chitosan nanoparticles to protect the shrimp from white spot syndrome virus (WSSV). Fish Shellfish Immunol. 2009;26:429-37.
149. Rao M, Sockanathan S. Molecular mechanisms of RNAi: implications for development and disease. Birth Defects Res C. 2005;75:28-42.
150. Rao M, Baraban JH, Rajaii F, Sockanathan S. In vivo comparative study of RNAi methodologies by in ovo electroporation in the chick embryo. Dev Dyn. 2004;231:592-600.
151. Raoni M, Arndt GM. Double-stranded RNA-mediated gene silencing in fission yeast. Nucleic Acids Res. 2003;31:4481-9.
152. Reavy B, Dawson S, Canto T, MacFarlane SA. Heterologous expression of plant virus genes that suppress post-transcriptional gene silencing results in suppression of RNA interference in Drosophila cells. BMC Biotechnol. 2004;4:18.
153. Reinhart BJ, Bartel DP. Small RNAs correspond to centromere heterochromatic repeats. Science. 2002;297:1831.
154. Robalino J, Bartlett T, Shepard E, Prior S, Jaramillo G, Scura E, Chapman RW, Gross PS, Browdy CL, Warr GW. Double-stranded RNA induces sequence-specific antiviral silencing in addition to nonspecific immunity in a marine shrimp: convergence of RNA interference and innate immunity in the invertebrate antiviral response? J Virol. 2005;79:13561-71.
155. Robalino J, Bartlett TC, Chapman RW, Gross PS, Browdy CL, Warr GW. Double-stranded RNA and antiviral immunity in marine shrimp: inducible host mechanisms and evidence for the evolution of viral counter-responses. Dev Comp Immunol. 2007;31:539-47.
156. Robbins PD, Ghivizzani SC. Viral vectors for gene therapy. Pharmacol Ther. 1998;80:35-47.
157. Roignant JY, Carre C, Mugat B, Szymczak D, Lepesant JA, Antoliewski C. Absence of transitive and systemic pathways allows cell-specific and isoform-specific RNAi in Drosophila. RNA. 2003;9:299-308.
158. Rolling F, Samulski RJ. AAV as a viral vector for human gene therapy. Generation of recombinant virus. Mol Biotechnol. 1995;3:9-15.
159. Rosema DB, Lewis DL, Wakefield DH, Wong SC, Klein JJ, Roesch PL, Bertin SL, Reppin TW, Chu Q, Blokhin AV, Hagstrom JE, Wolff JA. Dynamic polyconjugates for targeted in vivo delivery of siRNA to hepatocytes. Proc Natl Acad Sci USA. 2007;104:12982-7.
160. Roy P. Baculovirus solves a complex problem. Nat Biotechnol. 2004;22:1527-8.
161. Russell DW, Alexander IE, Millar D. DNA synthesis and topoisomerase inhibitors increase transduction by adeno-associated virus vectors. Proc Natl Acad Sci USA. 1995;92:5719-23.
162. Saxena S, Jonsson ZO, Dutta A. Small RNAs with imperfect match to endogenous mRNA repress translation. J Biol Chem. 2003;278:44312-44319.
163. Scacheri PC, Rozenblatt-Rosen O, Caplen NJ, Wolfsberg TG, Umayam L, Lee JC, Hughes CM, Shanmugam KS, Bhattacharjee A, Meyerson M, Collins FS. Short interfering RNAs can induce unexpected and divergent changes in the levels of untargeted proteins in mammalian cells. Proc Natl Acad Sci USA. 2004;101:1892-7.
164. Schmidt-Wolf GD, Schmidt-Wolf IGH. Non-viral and hybrid vectors in human gene therapy: an update. Trends Mol Med. 2003;9:67-72.
165. Schwarz DS, Hutvagner G, Haley B, Zamore PD. Evidence that siRNAs function as guides, not primers, in the Drosophila and human RNAi pathways. Mol Cell. 2002;10:537-48.
166. Schwarz DS, Hutvagner G, Du T, Xu Z, Aronin N, Zamore PD. Asymmetry in the assembly of the RNAi enzyme complex. Cell. 2003;115:199-208.
167. Shanker P, Manjunath N, Lieberman J. The prospect of silencing disease using RNA interference. J Am Med Assoc. 2005;293:1367-73.
168. Sijen T, Fleenor J, Simmer F, Thijssen KL, Parrish S, Timmons L, Plasterk RHA, Fire A. On the role of RNA amplification in dsRNA-triggered gene silencing. Cell. 2001;107:465-76.
169. Silhavy D, Molnar A, Lucioli A, Szittya G, Hornyik C, Tavazza M, Burgyan J. A viral protein suppresses RNA silencing and binds silencing-generated, 21-25-nucleotide double-standed RNAs. EMBO J. 2002;21:3070-80.
170. Singh SK. RNA interference and its therapeutic potential against HIV infection. Expert Opin Biol Ther. 2008;8:449-61.
171. Smith GE, Summers MD, Fraser MJ. Production of human beta interferon in insect cells with a baculovirus expression vector. Mol Cell Biol. 1983;3:2156-65.
172. Snyder RO. Adeno-associated virus-mediated gene delivery. J Gene Med. 1999;1:166.
173. Sohail M, Doran G, Riedemann J, Macaulay V, Southern EM. A simple and cost-effective method for producing small interfering RNAs with high efficacy. Nucleic Acids Res. 2003;30:e46.
174. Song E, Zhu P, Lee SK, Chowdhury D, Kussman S, Dykxhoorn DM, Feng Y, Palliser D, Weiner DB, Shanker P, Marasco WA, Lieberman J. Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors. Nat Biotechnol. 2005;23:709-17.
175. Sos-Hegedus A, Lovas A, Kondrak M, Kovacs G, Banfalvi Z. Active RNA silencing at low temperature indicates distinct pathways for antisense-mediated gene-silencing in potato. Plant Mol Biol. 2005;59:595-602.
176. Su J, Oanh DTH, Lyons RE, Leeton L, van Hulten MCW, Tan SH, Song L, Rajendran KV, Walker PJ. A key gene of the RNA interference pathway in the black tiger shrimp, Penaeus monodon: identification and functional characterisation of Dicer-1. Fish Shell Immunol. 2008;24:223-33.
177. Sui G, Soohoo C, Affar EB, Gay F, Shi Y, Forrester WC, Shi Y. A DNA vector-based RNAi technology to suppress gene expression in mammalian cells. Proc Natl Acad Sci USA. 2002;99:5515-20.
178. Sun JY, Anand-Jawa V, Chatterjee S, Wong KK. Immune responses to adeno-associated virus and its recombinant vectors. Gene Ther. 2003;10:964-76.
179. Tabara H, Sarkissian M, Kelly WG, Fleenor J, Grishok A, Timmons L, Fire A, Mello CC. The rde-1 gene, RNA interference and transposon silencing in C. elegans. Cell 1999;99.
180. Tabara H, Yigit E, Siomi H, Mello CC. The dsRNA binding protein RDE-4 interacts with RDE-1, DCR-1, and a DExH-Box helicase to direct RNAi in C. elegans. Cell. 2003;109:861-71.
181. Takei Y, Kadmoatsu K, Yuzawa Y, Matsuo S, Muramatsu T. A small interfering RNA targeting vascular endothelial growth factor as cancer therapeutics. Cancer Res. 2004;64:3365-70.
182. Tenllado F, Llave C, Diaz-Ruiz JR. RNA interference as a new biotechnological tool for the control of virus diseases in plants. Virus Res. 2001;102:85-96.
183. Thomas M, Klibanov AM. Non-viral gene therapy: polycation-mediated DNA delivery. Appl Microbiol Biotechnol. 2003;62:27-34.
184. Timmons L, Court DL, Fire A. Ingestion of bacterially expressed dsRNAs can produce specific and potent genetic interference in Caenorhabditis elegans. Gene. 2001;263:103-12.
185. Travanty EA, Adelman ZN, Franz AW, Keene KM, Beaty BJ, Blair CD, James AA, Olson KE. Using RNA interference to develop dengue virus resistance in genetically modified Aedes aegypti. Insect Biochem Mol Biol. 2004;34:607-13.
186. Tucker M, Han M. Muscle cell migrations of C. elegans are mediated by the alpha-integrin INA-1, Eph receptor VAB-1, and a novel peptidase homologue MNP-1. Dev Biol. 2008;318:215-23.
187. Vaistij FE, Jones L, Baulcombe D. Spreading of RNA targeting and DNA methylation in RNA silencing requires transcription of the target gene and a putative RNA-dependent RNA polymerase. Plant Cell. 2002;14:857-67.
188. Van der Krol AR, Mur LA, Beld M, Mol JNM, Stuitje AR. Flavonoid genes in petunia: addition of a limited number of gene copies may lead to a suppression of gene expression. Plant Cell. 1990;2:291-9.
189. Van Houdt H, Bleys A, Depicker A. RNA target sequences promote spreading of RNA silencing. Plant Physiol. 2003;131:245-53.
190. Vanitharani R, Chellappan P, Fauquet CM. Short interfering RNA-mediated interference of gene expression and viral DNA accumulation in cultured plant cells. Proc Natl Acad Sci USA. 2003;100:9632-6.
191. Verma M. A tumultuous year for gene therapy. Mol Ther. 2000;2:415-6.
192. Verma IM, Somia N. Gene therapy- promises, problems and prospects. Nature. 1997;389:239-42.
193. Voinnet O, Pinto YM, Baulcombe D. Suppression of gene silencing: a general strategy used by diverse DNA and RNA viruses of plants. Proc Natl Acad Sci USA. 1999;96:14147-52.
194. Wang Q, Finer MH. Second-generation adenovirus vectors. Nat Med. 1996;2:714-6.
195. Wang S, Liu H, Ren L, Pan Y, Zhang Y. Inhibiting colorectal carcinoma growth and metastasis by blocking the expression of VEGF using RNA interference. Neoplasia. 2008;10:399-407.
196. Waterhouse PM, Graham MW, Wang MB. Virus resistance and gene silencing in plants can be induced by simultaneous expression of sense and antisense RNA. Proc Natl Acad Sci USA. 1998;95:13959-64.
197. Westenberg M, Heinhuis B, Zuidema D, Vlak JM. siRNA injection induces sequence-independent protection in Penaeus monodon against white spot syndrome virus. Virus Res. 2005;114:133-9.
198. Wianny F, Zernicka-Goetz M. Specific interference with gene function by double-stranded RNA in early mouse development. Nat Cell Biol. 2000;2:70-5.
199. Wickham TJ, Carrion ME, Kovesdi I. Targeting of adenovirus penton base to new receptors through replacement of its RGD motif with other receptor-specific peptide motifs. Gene Ther. 1995;2:750-6.
200. Wickham TJ, Segal DM, Roelvink PW, Carrion ME, Lizonova A, Lee GM, Kovesdi I. Targeted adenovirus gene transfer to endothelial and smooth muscle cells by using bispecific antibodies. J Virol. 1996;70:6831-8.
201. Williams RW, Rubin GM. ARGONAUTE1 is required for efficient RNA interference in Drosophila embryos. Proc Natl Acad Sci USA. 2002;99:6889-94.
202. Wu-Scharf D, Jeong B, Chang C, Cerutti H. Transgene and transposon silencing in Chlamydomonas reinhardtii by a DEAH-box RNA helicase. Science. 2000;290:1159-62.
203. Yang Y, Wilson JM. Clearance of adenovirus-infected hepatocytes by MHC class I-restricted CD4+CTLs in vivo. J Immunol. 1995;155:2564-70.
204. Yang Y, Su Q, Wilson JM. Role of viral antigens in destructive cellular immune responses to adenovirus vector-transduced cells in mouse lungs. J Virol. 1996;70:7209-12.
205. Yang D, Lu H, Erickson JW. Evidence that processed small dsRNAs may mediate sequence-specific mRNA degradation during RNAi in Drosophila embryos. Curr Biol. 2000;10:1191-200.
206. Yang D, Buchholz F, Huang Z, Goga A, Chen CY, Brodsky FM, Bishop JM. Short RNA duplexes produced by hydrolysis with Escherichia coli RNase III mediate effective RNA interference in mammalian cells. Proc Natl Acad Sci USA. 2002;99:9942-7.
207. Yodmuang S, Tirasophon W, Roshorm Y, Chinnirunvong W, Panyim S. YHV-protease dsRNA inhibits YHV replication in Penaeus monodon and prevents mortality. Biochem Biophys Res Commun. 2006;341:351-6.
208. Yoshida Y, Emi N, Hamada H. VSV-G-pseudotyped retroviral packaging through adenovirus-mediated inducible gene expression. Biochem Biophys Res Commun. 1997;232:379-82.
209. Zambon RA, Vakharia VN, Wu LP. RNAi is an antiviral immune response against a dsRNA virus in Drosophila melanogaster. Cell Microbiol. 2006;8:880-9.
210. Zamore PD, Tuschi T, Sharp PA, Bartel DP. RNAi: double-Stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals. Cell. 2000;101:25-33.
211. Zao MM, An DR, Zhao J, Huang GH, He ZH, Chen JY. Transiently expressed short hairpin RNA targeting 126 kDa protein of tobacco mosaic virus interferes with virus infection. Acta Biochim Biophys Sin. 2006;38:22-8.
212. Zeng Y, Cullen BR. RNA interference in human cells is restricted to the cytoplasm. RNA. 2002;8:855-60.
213. Zhu Q, Arakane Y, Beeman RW, Kramer KJ, Muthukrishnan S. Functional specialization among insect chitinase family genes revealed by RNA interference. Proc Natl Acad Sci USA. 2008;105:6650-65.